ARCHIVES

In Brief: Megastrol Acetate Still Under FDA Review; Mays Hired For NCI’s Technology Office

This article is from The Cancer Letter archive.

Vol. 16 No. 29 | July 20, 1990

Download PDF Visit The Full Archive

Related Articles

NCI Starts “Exceptional Responders” Study

September 26, 2014

New Government-Wide Regulatory Policy Set For Carcinogens; Industry Group Says They are Not Scientific

October 5, 1979

FDA Panel urges Breast Implant Studies, Says Devices Should Remain Available

November 22, 1991

Biology Societies Recomend 15% Funding Increase for NIH

February 12, 1999

NIH Proposes Center for Cell Biology

February 19, 1993

Galeterone Shows Potential In CRPC AR Variants, Study Says

November 28, 2014